These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26967893)

  • 1. Distinguishing Antimicrobial Models with Different Resistance Mechanisms via Population Pharmacodynamic Modeling.
    Jacobs M; Grégoire N; Couet W; Bulitta JB
    PLoS Comput Biol; 2016 Mar; 12(3):e1004782. PubMed ID: 26967893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of appropriate antimicrobial dosing: pharmacokinetic and pharmacodynamic considerations.
    Preston SL
    Ann Pharmacother; 2004 Sep; 38(9 Suppl):S14-8. PubMed ID: 15226489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision.
    Chua HC; Tse A; Smith NM; Mergenhagen KA; Cha R; Tsuji BT
    Int J Antimicrob Agents; 2021 Mar; 57(3):106269. PubMed ID: 33358761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New concept and a theoretical consideration of the mechanism-based pharmacokinetics/ pharmacodynamics (PK/PD) modeling for antimicrobial agents.
    Sato N; Suzuki H; Hayashi H; Shibasaki S; Sugano T; Maebashi K; Kurosawa T; Shiomi M; Ogata H
    Jpn J Antibiot; 2008 Oct; 61(5):314-38. PubMed ID: 19260351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining optimal dosing regimen of oral administration of dicloxacillin using Monte Carlo simulation.
    Yu W; Ji J; Xiao T; Ying C; Fang J; Shen P; Xiao Y
    Drug Des Devel Ther; 2017; 11():1951-1956. PubMed ID: 28721014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating amikacin dosage regimens in intensive care unit patients: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.
    Zazo H; Martín-Suárez A; Lanao JM
    Int J Antimicrob Agents; 2013 Aug; 42(2):155-60. PubMed ID: 23756322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-mechanistic pharmacokinetic-pharmacodynamic modelling of antibiotic drug combinations.
    Brill MJE; Kristoffersson AN; Zhao C; Nielsen EI; Friberg LE
    Clin Microbiol Infect; 2018 Jul; 24(7):697-706. PubMed ID: 29229429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives.
    de Velde F; Mouton JW; de Winter BCM; van Gelder T; Koch BCP
    Pharmacol Res; 2018 Aug; 134():280-288. PubMed ID: 30033398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A network-based approach for resistance transmission in bacterial populations.
    Gehring R; Schumm P; Youssef M; Scoglio C
    J Theor Biol; 2010 Jan; 262(1):97-106. PubMed ID: 19747924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics in antibiotic dose optimization.
    Sy SK; Zhuang L; Derendorf H
    Expert Opin Drug Metab Toxicol; 2016; 12(1):93-114. PubMed ID: 26652832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic/pharmacodynamic model-based combination therapy approach to target antibiotic resistant populations emerged from ciprofloxacin exposure.
    Wu B; Derendorf H
    Pharmazie; 2010 Jun; 65(6):417-20. PubMed ID: 20614689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing.
    Mohamed AF; Cars O; Friberg LE
    J Antimicrob Chemother; 2014 May; 69(5):1350-61. PubMed ID: 24474432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple in vitro PK/PD model system to determine time-kill curves of drugs against Mycobacteria.
    Budha NR; Lee RB; Hurdle JG; Lee RE; Meibohm B
    Tuberculosis (Edinb); 2009 Sep; 89(5):378-85. PubMed ID: 19748318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
    Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
    J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic/pharmacodynamic analysis in microbiology: a tool for the evaluation of the antimicrobial treatment].
    Canut Blasco A; Aguilar Alfaro L; Cobo Reinoso J; Giménez Mestre MJ; Rodríguez-Gascón A
    Enferm Infecc Microbiol Clin; 2015 Jan; 33(1):48-57. PubMed ID: 23850188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting mutant selection in competition experiments with ciprofloxacin-exposed Escherichia coli.
    Khan DD; Lagerbäck P; Malmberg C; Kristoffersson AN; Wistrand-Yuen E; Sha C; Cars O; Andersson DI; Hughes D; Nielsen EI; Friberg LE
    Int J Antimicrob Agents; 2018 Mar; 51(3):399-406. PubMed ID: 29127049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing dosage to prevent emergence of resistance - lessons from in vitro models.
    Singh R; Tam VH
    Curr Opin Pharmacol; 2011 Oct; 11(5):453-6. PubMed ID: 21868287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction.
    Ahmad I; Huang L; Hao H; Sanders P; Yuan Z
    Biomed Res Int; 2016; 2016():5465678. PubMed ID: 26989688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanism-based pharmacokinetic/pharmacodynamic model allows prediction of antibiotic killing from MIC values for WT and mutants.
    Khan DD; Lagerbäck P; Cao S; Lustig U; Nielsen EI; Cars O; Hughes D; Andersson DI; Friberg LE
    J Antimicrob Chemother; 2015 Nov; 70(11):3051-60. PubMed ID: 26349518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.